5 days ago · Financing led by US life sciences investor, BroadOak Capital Partners Investment to support expansion of US operations, product development, and cell manufacturing scale-up Axol …

With over a decade of expertise, Axol partners with global pharmaceutical companies, contract research organizations (CROs), biotechnology firms, start-ups, and academic institutions to advance the use …

4 days ago · Axol's next phase of growth will expand its U.S. operations and development in response to increasing global customer demand.

Axol Bioscience announced it has raised $2.8 million (£2.1 million) in funding to expand its US operations, advance product development, and scale cell manufacturing capacity. The financing was …

4 days ago · Axol Bioscience Raises $2.8M to Advance US Expansion and Product Development Financing led by US life sciences investor, BroadOak Capital Partners Investment to support …

4 days ago · Axol Bioscience Ltd. (Axol), a leading provider of induced pluripotent stem cell (iPSC) technologies for drug discovery and disease research, today announced that it has secured $2.8 …

5 days ago · Axol has recently established itself as a leader in provision of physiologically relevant iPSC-derived models for neurodegenerative disorders including Huntington’s disease and sporadic …

5 days ago · Financing led by US life sciences investor, BroadOak Capital Partners Investment to support expansion of US operations, product development, and cell manufacturing scale-up …

4 days ago · Investment to support expansion of US operations, product development, and cell manufacturing scale-up Axol Bioscience Ltd. (Axol), a leading provider of induced pluripotent stem …

Jul 9, 2025 · Together, the expanded Axol family now offers a broader range of products, including melanocytes, sebocytes, and retinal pigment epithelial cells, and can also develop a wider range of …